glp 1 antagonist exendin Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway Achieve your results faster with highly validated Exendin(9‐39)NH2: Recommendations for clinical use
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9








.png?w=1280&max-h=720&fit=crop&auto=format)













